Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Northwest Biotherapeutics
Biotech
Troubled Northwest Bio adds Merck alum to management team
Northwest Biotherapeutics has hired Kevin Duffy, Ph.D., who worked on Merck's PD-1 drug Keytruda from its early days through commercialization.
Amirah Al Idrus
Sep 5, 2019 8:25am
Northwest Bio's glioblastoma vaccine data see stock roller coaster
May 30, 2018 7:25am
FDA lifts clinical hold on Northwest Bio cancer vax trial
Feb 7, 2017 5:55am
After Woodford takes a bath on NW Bio, British investor decides to towel off
Dec 12, 2016 4:34am
Northwest Bio trial hold still on, comes under pressure from Nasdaq
May 3, 2016 4:31am
